Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration ...

Deep within the Apple operating system are capabilities that allow users to summon apps, send emails and texts, play music ...

The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase ...

In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched controls who hadn't.

Background Amyotrophic lateral sclerosis overlaps aetiologically and genetically with ... lifetime risks of 1 in 386.4 for ALS (combining both male and female incidence) and 1 in 305 for FTD have been ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

It also develops therapies for various neurological diseases such as amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury and chemotherapy-induced peripheral neuropathy. Nura Bio ...

a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS). Under the leadership of Principal Investigator Prof Merit Cudkowicz, MD, Director of the Sean M. Healey ...

Introduction: T regulatory cells (Tregs) inversely correlate with disease progression in Amyotrophic Lateral Sclerosis (ALS ... PD1+Tregs decreased and CD39+Tregs increased over time. Male sex and ...

Objectives: Amyotrophic lateral sclerosis (ALS) is a progressive ... A rare adverse event was reported in a 35-year-old male patient, who experienced diarrhea up to more than ten times per day after ...